ZELSUVMI: A Breakthrough in Drug Innovation with FDA Approval for Berdazimer Sodium
ZELSUVMI: A Breakthrough in Drug Innovation with FDA Approval for Berdazimer Sodium The U.S. Food and Drug Administration (FDA) recently approved ZELSUVMI (NDA #217424) as a new molecular entity (NME), representing a significant milestone in drug innovation. This article delves into the significance of this approval, the science behind Berdazimer Sodium, and what this…